- Roche, Novo Nordisk, and Bristol-Myers Squibb are evaluating new drug candidates for Parkinson's, ATTR amyloidosis, and Alzheimer's diseases.
- CMS introduced the Medicare drug price negotiation program, and companies are facing challenges regarding pricing and market access.
Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Major pharmaceutical companies are part of the ten largest global pharma giants as the industry seeks to weaken drug price negotiation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Pfizer
American multinational pharmaceutical and biotechnology corporation